iCAD announced a philanthropic global health collaboration with RAD-AID International. RAD-AID, a non-profit charitable organization dedicated to improving radiology healthcare in medically underserved regions, is collaborating with iCAD to introduce mammography AI-based decision support in LMICs, starting with an implementation in Guyana using iCAD’s ProFound Detection. The partnership’s primary goal is to improve the speed, efficiency and accuracy of breast imaging and breast cancer detection by providing low-resource medical institutions with access to technology, education, clinical support, and hands-on training. iCAD and RAD-AID aim to begin in Guyana where implementation of iCAD’s ProFound AI Detection Solution, coupled with RAD-AID’s educational and capacity-building initiatives, aims to increase, and improve breast cancer detection for patients in need. Such collaboration endeavors to build AI-supported models for globally reducing health care disparities and increasing health equity by widening access to earlier cancer diagnostics.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICAD:
- iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale
- iCAD releases enhanced ProFound Detection workstation
- iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
- iCAD highlights scientific presentations at ECR annual meeting
- iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings
Questions or Comments about the article? Write to editor@tipranks.com